Tightens Medicare rules for telehealth-related orders and claims. Medicare will not pay for high‑cost durable medical equipment (DME) or high‑cost lab tests ordered after a telehealth visit unless the ordering clinician saw the patient in person at least once in the prior 6 months. Medicare contractors must also review claims and audit clinicians who order an unusually high share of these items via telehealth.

Requires physicians and practitioners to include their National Provider Identifier (NPI) on claims for separately billable telehealth services. Starting 180 days after enactment, Medicare will deny payment for such telehealth claims that do not include the billing provider’s NPI.